1993
DOI: 10.1016/s0021-9258(18)53479-7
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of the acyl chain specificities of human myristoyl-CoA synthetase and human myristoyl-CoA:protein N-myristoyltransferase.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
28
0

Year Published

1993
1993
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 69 publications
(28 citation statements)
references
References 74 publications
0
28
0
Order By: Relevance
“…The preference for glycine is well understood from structural studies as the side chain of other amino acids are not tolerated in the active site because of steric reasons . However, recent studies demonstrated that human NMT1/2 can also catalyze the myristoylation of lysine 3 side chain of ARF6 protein. , Previously, the activity of partially purified human NMT was tested on a variety of acyl-CoA molecules ranging from C7 to C16, and myristoyl-CoA is shown to be the most preferred substrate . However, shorter acyl-CoA molecules were not tested.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The preference for glycine is well understood from structural studies as the side chain of other amino acids are not tolerated in the active site because of steric reasons . However, recent studies demonstrated that human NMT1/2 can also catalyze the myristoylation of lysine 3 side chain of ARF6 protein. , Previously, the activity of partially purified human NMT was tested on a variety of acyl-CoA molecules ranging from C7 to C16, and myristoyl-CoA is shown to be the most preferred substrate . However, shorter acyl-CoA molecules were not tested.…”
Section: Resultsmentioning
confidence: 99%
“…5,6 Previously, the activity of partially purified human NMT was tested on a variety of acyl-CoA molecules ranging from C7 to C16, and myristoyl-CoA is shown to be the most preferred substrate. 7 However, shorter acyl-CoA molecules were not tested. Surprisingly, when we tested recombinant h u m a n N M T 1 w i t h A R F 6 N -t e r m i n a l p e p t i d e (GKVLSKIFWW), we found that acetyl-CoA can also be used as a substrate, leading to the formation of an acetyl peptide product (Figure 1).…”
mentioning
confidence: 99%
“…Several studies have shown that NMT is a potential target for antifungal and antiparasite ,, drugs because it is indispensable for the growth and viability of fungal and parasitic organisms. Moreover, compared with the myristoyl-CoA binding site, the peptide binding pocket of NMT is less well-conserved across species . The pocket can therefore be targeted for the development of selective NMT inhibitors.…”
Section: N-terminal Glycine Myristoylationmentioning
confidence: 99%
“…Moreover, compared with the myristoyl-CoA binding site, the peptide binding pocket of NMT is less well-conserved across species. 339 The pocket can therefore be targeted for the development of selective NMT inhibitors. Several series of inhibitors (Figure 17) from high-throughput screening have been reported for NMTs in humans, 340 parasites (P. falciparum, Leishmania sp., T. brucei), 338,341−344 and fungi.…”
Section: Chemical Reviewsmentioning
confidence: 99%
“…MyrCoA analogs can be obtained in vitro from free CoA and any FA derivative using either chemical or enzymatic approaches [151][152][153]. From studies of such compounds, it appears that NMT can also efficiently accommodate C10 to C15 chains [154,155] and appears to tolerate variations at the extreme side of the acyl chain beyond C5/6 [156][157][158]. Nevertheless, C14:0 is considered the major acyl form used by NMT.…”
Section: Main Structural and Biochemical Features Of Nmtsmentioning
confidence: 99%